Common use of Program Steering Committee Clause in Contracts

Program Steering Committee. The Program Steering Committee (the “Program Steering Committee”) will oversee activities under the revised Master Development Plans. 4.2 The Program Steering Committee shall meet one time, no later than one hundred and eighty (180) days after SoPD for the first Replacement Collaboration Compound. With the exception of this post-SoPD meeting, the meetings of the Program Steering Committee shall be suspended until the earlier of (a) the Filing with the U.S. Food and Drug Administration of the first Investigational New Drug Application for the first Replacement Collaboration Compound for ZP2929, or (b) the first ethical committee approval of a Phase I Clinical trial for the first Replacement Collaboration Compound for ZP2929. Thereafter, the Program Steering Committee shall meet as further outlined in Section 2.3 of the GGDA Agreement. 4.3 For so long as meetings of the Program Steering Committee are suspended as provided in Section 4.2 above, BI’s research team (until. SoPD) and BI’s development team (after SoPD) shall provide Zealand Pharma’s research team, every six (6) months after the Amendment 2 Effective Date, with a summary update in reasonable detail about its research activities for candidate Replacement Collaboration Compounds and its performance of the Summary Research Plan.. Such summary reports shall include the items described in Appendix 4.3 to this Amendment 2. In order to ensure an efficient exchange of information relevant to the Summary Research Plan, should Zealand Pharma so request, not more than three (3) designees from the research teams of each of BI and. Zealand Pharma shall meet by videoconference or telephone conference once in each of the first and third Calendar Quarters, to discuss the status of and path forward for BI’s research activities.